T
0.320
-0.05 (-12.57%)
| Penutupan Terdahulu | 0.366 |
| Jumlah Dagangan | 629 |
| Harga / Jualan (P/S) | 2.03 |
| Harga / Buku (P/B) | 3.09 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -9,128.07% |
| EPS Cair (TTM) | -27.20 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 1.80% |
| Nisbah Semasa (MRQ) | 1.81 |
| Aliran Tunai Operasi (OCF TTM) | -30.80 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -14.51 M |
| Pulangan Atas Aset (ROA TTM) | -83.59% |
| Pulangan Atas Ekuiti (ROE TTM) | -2,331.25% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Traws Pharma, Inc. | Bercampur | - |
AISkor Stockmoo
-0.2
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -2.5 |
| Persekitaran Makro | 0.0 |
| AI Insight | NA |
| Purata | -0.17 |
|
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 18.86% |
| % Dimiliki oleh Institusi | 31.23% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Orbimed Advisors Llc | 30 Jun 2026 | 1,203,260 |
| Lynx1 Capital Management Lp | 30 Jun 2026 | 559,470 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |